Valisure’s Co-Founder & President David Light recently joined (Ret.) Col. Victor Suarez at a Legislative Briefing hosted by the Hypertrophic Cardiomyopathy Association (HCMA) to discuss their collaborative work with the Department of Defense to independently test and rate the quality of essential medications.

Their remarks centered on Valisure’s development of a “Red / Yellow / Green” quality score system for drug suppliers used across the Military Health System—bringing transparency and accountability to medications critical for cardiology and transplant care, including metoprolol and tacrolimus.

This initiative is part of a broader effort to attach objective chemical quality scores to National Drug Codes (NDCs), making it possible for all U.S. health systems to factor quality into procurement decisions. With this scoring system in place, high-quality and affordable medications can be incentivized simply by prioritizing “green” rated products and avoiding those rated “red.”

Valisure is deeply appreciative that drug quality improvement is now one of HCMA’s top legislative priorities, and proud to support a topic gaining bipartisan momentum on Capitol Hill.

Thanks to the DoD’s leadership and collaboration, the industry now has not only the data—but also the tools—to take meaningful action on medication safety and reliability.

Watch the full briefing recording here.

‍

Valisure’s Co-Founder & President David Light recently joined (Ret.) Col. Victor Suarez at a Legislative Briefing hosted by the Hypertrophic Cardiomyopathy Association (HCMA) to discuss their collaborative work with the Department of Defense to independently test and rate the quality of essential medications.

Their remarks centered on Valisure’s development of a “Red / Yellow / Green” quality score system for drug suppliers used across the Military Health System—bringing transparency and accountability to medications critical for cardiology and transplant care, including metoprolol and tacrolimus.

This initiative is part of a broader effort to attach objective chemical quality scores to National Drug Codes (NDCs), making it possible for all U.S. health systems to factor quality into procurement decisions. With this scoring system in place, high-quality and affordable medications can be incentivized simply by prioritizing “green” rated products and avoiding those rated “red.”

Valisure is deeply appreciative that drug quality improvement is now one of HCMA’s top legislative priorities, and proud to support a topic gaining bipartisan momentum on Capitol Hill.

Thanks to the DoD’s leadership and collaboration, the industry now has not only the data—but also the tools—to take meaningful action on medication safety and reliability.

Watch the full briefing recording here.

‍